Showing results (2201-2210 of 2,492) with videos related to
Sort By:
Pageof 250
The Lancet. Oncology|December 10, 2016
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 studyCharles M Rudin, M Catherine Pietanza, Todd M Bauer, et al.Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.Journal for Immunotherapy of Cancer|January 21, 2022
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter studyPaolo Andrea Zucali, Chia-Chi Lin, Bradley C Carthon, et al.World Journal of Urology|May 6, 2018
The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?Tanja Hüsch, Alexander Kretschmer, Frauke Thomsen, et al.Journal of the American Medical Directors Association|July 15, 2015
Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trialJürgen M Bauer, Sjors Verlaan, Ivan Bautmans, et al.The Lancet. Oncology|November 11, 2018
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 studyBenjamin J Solomon, Benjamin Besse, Todd M Bauer, et al.Calcified Tissue International|July 25, 2019
Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid TumorsAung Naing, Kyriakos P Papadopoulos, Karen A Autio, et al.Molecular Phylogenetics and Evolution|March 20, 2018
Phylogeny and biogeography of the African burrowing snake subfamily Aparallactinae (Squamata: Lamprophiidae)Frank Portillo, William R Branch, Werner Conradie, et al.Pageof 250